MedTrace Logo

Fluid Management for Cesarean Section II

NCT00973791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 860

Last updated 2009-09-09

No results posted yet for this study

Summary

Fluid management plays an essential role in cesarean section. In previous study (NCT00488111) the investigators found that prior-epidural anesthesia fluid management produced a more significant role in stabilizing the blood pressure and better prognosis after cesarean delivery than that of the posterior-anesthesia ones. Given epidural anesthesia has a time interval before reaching the best state of anesthesia, so the fluid management also has a relatively adequate time to resuscitation. In reality, spinal anesthesia is used popularly except for the epidural anesthesia, whereas spinal anesthesia would produce more significant fluctuation of the hemodynamics compared with the latter. Herein the investigators proposed whether the prior-spinal anesthesia fluid management also produced similar effect on hemodynamic characteristics to the epidural anesthesia.

Conditions

  • Cesarean Section

Interventions

DRUG

Ringer's Lactate

Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section

DRUG

Six percent hydroxyethyl starch

Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section

Sponsors & Collaborators

  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER

  • Nanjing Medical University

    lead OTHER

Principal Investigators

  • XiaoFeng Shen, MD · Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973791 on ClinicalTrials.gov